Lineage Cell Therapeutics
LCTX • AMEX
Lineage Cell Therapeutics is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Brian Culley, with a market cap of $371.1M.
Market Cap$371.1M
Employees75.0
CEOBrian Culley
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Lineage Cell Therapeutics FAQ
Common questions about Lineage Cell Therapeutics
Lineage Cell Therapeutics is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $3.7M.
Lineage Cell Therapeutics has approximately 75 employees.